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Abstract:  
 
Cardiac output during right-sided heart catheterization is an important variable for patient 
selection of advanced therapies (cardiac transplantation and left ventricular assist device 
implantation). The Fick method to determine cardiac output is commonly used and typically uses 
estimated oxygen consumption (VO2) from 1 of 3 published empirical formulas. However, these 
estimation equations have not been validated in patients with heart failure and reduced ejection 
fraction (HFrEF). The objectives of the present study were to determine the accuracy of 3 
equations for estimating VO2 compared with direct measurement of VO2 and determine the 
extent clinically significant error occurred in calculating cardiac output of patients with HFrEF. 
Breath-by-breath measurements of VO2 from 44 patients who underwent cardiac catheterization 
(66% men; age, 65 ± 11 years, left ventricular ejection fraction, 22 ± 6%) were compared with 
the derived estimations of LaFarge and Miettinen, Dehmer et al, and Bergstra et al. Single-
sample ttests found only the mean difference between the estimation of LaFarge and Miettinen 
and the measured VO2 to be nonsignificant (−10.3 ml/min ± 6.2 SE, p = 0.053). Bland-Altman 
plots demonstrated unacceptably large limits of agreement for all equations. The rate of ≥25% 
error in the equations by LaFarge and Miettinen, Dehmer et al, and Bergstra et al occurred in 
11%, 23%, and 45% of patients, respectively. Misclassification of cardiac index derived from 
each equation for 2 clinically important classifications: cardiogenic shock–21%, 23%, and 32% 
and hypoperfusion–16%, 16%, and 25%; respectively. In conclusion, these findings do not 
support the use of these empiric formulas to estimate the VO2 at rest in patients with HFrEF who 
underwent right-sided heart catheterization. 
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Article:  
 
Cardiac output during right-sided heart catheterization is an important variable for patient 
selection of advanced therapies (cardiac transplantation and left ventricular assist device 
implantation). The Fick method to determine cardiac output is commonly used and typically uses 
estimated oxygen consumption (VO2) from 1 of 3 published empirical formulas. However, these 
estimation equations have not been validated in patients with heart failure and reduced ejection 
fraction (HFrEF). The objectives of the present study were to determine the accuracy of 3 
equations for estimating VO2 compared with direct measurement of VO2 and determine the 
extent clinically significant error occurred in calculating cardiac output of patients with HFrEF. 
Breath-by-breath measurements of VO2 from 44 patients who underwent cardiac catheterization 
(66% men; age, 65 ± 11 years, left ventricular ejection fraction, 22 ± 6%) were compared with 
the derived estimations of LaFarge and Miettinen, Dehmer et al, and Bergstra et al. Single-
sample ttests found only the mean difference between the estimation of LaFarge and Miettinen 
and the measured VO2 to be nonsignificant (−10.3 ml/min ± 6.2 SE, p = 0.053). Bland-Altman 
plots demonstrated unacceptably large limits of agreement for all equations. The rate of ≥25% 
error in the equations by LaFarge and Miettinen, Dehmer et al, and Bergstra et al occurred in 
11%, 23%, and 45% of patients, respectively. Misclassification of cardiac index derived from 
each equation for 2 clinically important classifications: cardiogenic shock–21%, 23%, and 32% 
and hypoperfusion–16%, 16%, and 25%; respectively. In conclusion, these findings do not 
support the use of these empiric formulas to estimate the VO2 at rest in patients with HFrEF who 
underwent right-sided heart catheterization. 
 
It is standard practice to use the Fick method to estimate cardiac output in patients with heart 
failure and reduced ejection fraction (HFrEF).1 and 2 Using the Fick method requires the input of 
oxygen consumption (VO2) at rest but rather than measuring it directly, it is common practice to 
estimate VO2 at rest using 1 of 3 equations.3 All these assume a constant VO2 at rest based on a 
set of patient characteristics: body surface area (BSA),4, 5 and 6 age,4 and 6 gender,4 and 6 and heart 
rate.4 Despite their wide use in patients with HFrEF, these equations have not been well 
validated in this patient group. Therefore, the purpose of this study was to measure VO2 at rest in 
adult patients with HFrEF during right-sided heart catheterization procedures, investigate the 
accuracy of 3 widely used equations for the estimation of VO2 at rest compared with direct 
breath-by-breath measurement, and determine to what extent clinically significant errors occur 
when using estimation equations. 
 
METHODS 
 
This study was conducted in conjunction with the Cone Health Advanced Heart Failure Program, 
the cardiac catheterization laboratory at Moses H. Cone Memorial Hospital and the Department 
of Kinesiology at the University of North Carolina at Greensboro, Greensboro, North Carolina. 
All study procedures were concurrently approved by the institutional review boards of Cone 
Health and the University of North Carolina at Greensboro. All patients provided written 
informed consent before receiving sedation and any study-related procedures. There was no 
exclusion based on gender, race, or ethnicity. All patients scheduled for a right-sided heart 
catheterization with a left ventricular ejection fraction (LVEF) ≤40% within the previous 
6 months, with continued signs and symptoms consistent with HFrEF, and having not received 
intravenous inotropic therapy ≤7 days of the catheterization were considered for inclusion. 
Patients were excluded if they (1) were determined to have severe lung disease (diagnosed as 
such in the patient's medical history or, if spirometry data were available, a forced expiratory 
volume in 1second ≤1 L and/or a forced expiratory volume in 1 second to forced vital capacity 
ratio of ≤0.50, or required use of home O2), (2) were expected to receive >2 mg of midazolam 
and/or >50 μg of fentanyl, or (3) were expected to need supplemental O2 after receiving sedation. 
 
Appropriate medical history was obtained to determine the patient's candidacy for participation 
in the study, which included results of the patient's last LVEF measure and results of the last 
pulmonary function test (if available). In addition, age, gender, height, weight, and current list of 
medications were obtained. The results of the catheterization were also obtained after the 
procedure. 
 
VO2 at rest was measured using a commercial, open-circuit, breath-by-breath gas analysis system 
(Ultima-CPX, MGC Diagnostics Corp., St. Paul, Minnesota). System calibration was performed 
before each study according to the manufacturer's specifications. After the completion of the 
catheterization procedure, while the patient remained in the catheterization laboratory procedure 
room (supine on the laboratory table), the patient breathed through a mouthpiece with a noseclip 
occluding nasal ventilation. After a 5-minute run-in (acclimation) phase, sampling was 
performed for an additional 5 minutes. The reported value of VO2 at rest was the average during 
the 5-minute sampling period. 
 
Estimated VO2 at rest was calculated according to each of the 3 widely used empirical formulas 
listed in Table 1. In accordance with these equations, BSA was calculated according to the 
formula by D. Du Bois and E. Du Bois7: BSA (m2) = 0.007184 × weight (kg)0.425 × height 
(cm)0.725. 
 
 
 
All statistical analyses were done with JMP version 10 (SAS Institute Inc., Cary, North 
Carolina). With the exception of the mean differences, all continuous variables are reported as 
mean ± SD and categorical variables are reported as the total number (% of total). The mean 
differences are reported as mean ± SE. 
 
Single-sample t tests were performed to compare the mean of differences (estimated − measured) 
against the hypothetical mean difference of 0 and was considered statistically significantly 
different when p ≤0.05. 
 
The Bland-Altman method for comparing methods of measuring the same parameter was used to 
assess the agreement between measured and estimated VO2.8 In accordance with this method, % 
error of the estimation of VO2 at rest ([estimated − measured]/measured) for each patient was 
plotted against the corresponding average of the measured + estimated values. The limits of 
agreement were the mean difference ± 1.96 SD, and poor agreement was considered when the 
limits of agreement exceeded ± 25% error. 
 
Two different analyses were used to determine if differences between the measured and 
estimated VO2 were clinically significant. First, the absolute % error in estimated VO2was 
calculated by dividing the absolute value of the difference (estimated − measured) by the 
measured VO2. An absolute error ≥25% was considered the cut point for clinically significant 
error to occur.6, 2 and 9 Second, the actual clinically significant error rate of the sample was 
calculated based on the cardiac index (cardiac output/BSA). For each equation, data were plotted 
with the cardiac index derived from the measured VO2 along the x axis and the cardiac 
index derived from the estimate on the y axis. Break lines were laid over the plots at values 
representing the clinically important cutoffs10, 11 and 12 for cardiogenic shock 
(< or ≥1.9 ml/min/m2) and hypoperfusion (< or ≥2.2 ml/min/m2), resulting in plots with 4 
quadrants: 2 representing no clinically significant error (classification by the estimated VO2 = 
classification by measured VO2) and 2 representing clinically significant error (classification by 
the estimated VO2 ≠ classification by measured VO2). For each level, the number of patients 
falling in the clinically significant error quadrants for cardiac index was summed and divided by 
the total sample. 
 
RESULTS 
 
Forty-eight patients (75% men; age, 64 ± 11 years; LVEF, 22 ± 6%) were enrolled between 
August 2013 and August 2014. Four patients were withdrawn from the study before beginning 
collection of gas exchange: 1 patient received 4 mg of midazolam, 1 patient received 100 μg of 
fentanyl, 1 patient became hypoxic during the catheterization procedure (requiring O2), and 1 
patient had an LVEF >40% when ventriculogram was performed. All remaining patients 
completed the 10 minutes of breathing without difficulty or complication. 
 
Demographic data and catheterization and gas exchange results for the 44 patients completing 
10 minutes of gas exchange can be found in Tables 2 and 3. All patients with atrial fibrillation 
had appropriate rate control, which likely had little impact on VO2 at rest. Arterial and venous 
oxygen saturation and content from blood gas analysis can also be found in Table 3. 
 
The comparisons of the estimated versus the measured VO2 for the entire group and for each 
gender subgroup can be found in Table 4. The mean difference for the equation by LaFarge and 
Miettinen was found not to be significantly different for the entire group. Mean differences for 
the equations by Dehmer et al and Bergstra et al were found to be significantly different. 
Comparison of gender subgroups reveals that females have significant mean differences for both 
the equations by LaFarge and Miettinen and Dehmer et al. 
 
Figure 1, Figure 2 and Figure 3 are the Bland-Altman plots comparing the agreement between 
the estimated and measured VO2. The dotted lines represent the mean error ± 1.96 SD and the 
dashed lines represent the limits of agreement. All estimation equations have poor agreement 
with the measured VO2. The equation by LaFarge and Miettinen does not demonstrate a bias in 
the estimation. However, equation by Dehmer et al and Bergstra et al appears to have a bias 
toward overestimation. Although not presented, gender-specific Bland-Altman plots for both 
genders and for all 3 equations demonstrated large variability outside the limits of agreement. 
Another feature seen in the Bland-Altman plots (most distinctive in the estimations of Dehmer 
et al and Bergstra et al) is the systematic error of overestimating low VO2 and underestimating 
greater VO2, centering at ∼250 ml/min. 
 
 
 
 
 
 
Figure 4 demonstrates the rate at which patients with ≥25% absolute error occurred for each of 
the equations. Figure 5 demonstrates the process used to determine the clinically significant error 
rate. Table 5 presents the rates of the clinically significant error in the cardiac index derived from 
each estimation equation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
 
This study was designed to accomplish 2 goals. The first was to compare the level of agreement 
between the measured resting VO2 and the estimates from 3 commonly used prediction 
equations. This was accomplished with t tests of the differences and Bland-Altman analysis. It 
was hypothesized that each of the estimations would result in statistically significant differences 
compared with the measured VO2. The equations by Dehmer et al and Bergstra et al significantly 
overestimated VO2. However, the equations by LaFarge and Miettinen resulted in a 
nonsignificant underestimation. Importantly, use of a single-sample t test provides an objective 
evaluation of the mean difference, but only partially explains the discrepancy between the 
measured and estimated VO2. 
 
Bland-Altman plots reveal information about the mean difference that is not apparent in ttests. It 
was suggested by Bland and Altman that some variability of the difference between 2 
measurements should be expected, but the variability should be random (centering on a mean 
difference of 0), with a small range in the limits of agreement and without an apparent trend in 
differences across the range of measurements. 8 In the case of this analysis, all 3 estimations 
resulted in large ranges in the agreement between the measured and estimated VO2 that exceeded 
the predetermined acceptable range (±25%). In particular, although the equation by LaFarge and 
Miettinen did not produce a significantly different VO2 from measured values, the mean 
difference is derived from large differences both above and below 0. 
 
There are gender-specific corrections for the equation by LaFarge and Miettinen, and the 
findings from the mean differences suggest that the female-specific correction lessens the 
agreement with the measured VO2. This was also the case for the equation by Dehmer et al (does 
not have a gender-specific correction), which demonstrated a significant mean difference only 
for females. There was a similar result found by Narang et al3 with greater error in obese men 
than obese women owing the difference to the relatively greater lean mass in men. However, in 
the much larger analysis of a variety of clinically indicated right-sided heart catheterizations, 
nonsignificant differences were found between the genders, leading Narang et al to speculate on 
the need for including an adjustment for gender in the formulas by LaFarge and Miettinen and 
Bergstra et al.13The current analysis does not include a sufficient number of each gender to 
replicate the findings of Narang et al (2014) in this specific patient group. 
 
In addition, all the estimation equations, especially Dehmer et al and Bergstra et al, trend toward 
overestimating VO2 at lower values and underestimating it at greater values 
(Figure 3, Figure 4 and Figure 5). This trend has been a consistent finding in previous validation 
studies.2, 3, 5, 6, 9 and 13 
 
The second goal of the study was to investigate the rate at which each equation results in a 
clinically significant error. We hypothesized that each of the equations would result in ≥15% of 
the patients with ≥25% absolute error. This level was based on what has been suggested in the 
published studies as being the level at which clinically significant error (in the derived cardiac 
output) would most likely occur.2, 6 and 9 These results do not support this hypothesis. Particularly, 
the estimation by LaFarge and Miettinen resulted in 11.4% of patients falling in this category of 
absolute error. In the studies that have performed similar analysis, the equation by LaFarge and 
Miettinen had the lowest rates of patients with ≥25% error.2, 3, 9 and 13 In this sense, these results 
are consistent with the published studies. In the present study, estimation using the equation by 
Bergstra et al resulted in 48% of the patients with ≥25% error, corroborating previous research in 
HFrEF patients9 and strongly suggesting that this equation is inappropriate for use in clinical 
populations,9 and 13 especially those with HFrEF. 
 
Although the previously mentioned analyses were important in making comparisons with 
previous studies, further exploration of the true error resulting in a variable derived from the 
VO2 (e.g., cardiac index) can provide better insight into the real occurrence of clinically 
significant error. In the context of HFrEF, cardiac index is used particularly to help guide 
treatment and determine appropriateness for advanced therapies, such as cardiac transplant or left 
ventricular assist device (LVAD).10, 11, 12 and 14 For example, with patients being considered for 
LVAD, those who are found to be in cardiogenic shock have a significantly higher rates of major 
adverse events after LVAD implantation.11 Despite not currently being listed as an exclusion 
criteria, there has been a steady decrease in the percentage of patients receiving LVADs with 
cardiogenic shock since its recognition as a significant risk factor.15 So misclassifying patients 
either higher or lower can have significant influence on clinical decision making. 
 
Narang et al performed a similar analysis in a “hypothetical clinical context of aortic valve 
calculations,”13 only changing the subject's measured or estimated VO2.3 and 13Specifically, the 
analyses were performed in patients without heart disease before exercise testing3 and during 
clinically indicated right-sided heart catheterizations in 535 patients with a broad range of 
clinical indications (including 177 patients referred for HF–subanalysis of HF patients was not 
performed).13 Therefore, creating a hypothetical scenario homogenized the data for easier 
analysis. In the current analysis, the patients had HFrEF and the cardiac index was of particular 
clinical interest. So, understanding the real clinically significant error provides more direct 
clinical relevance, given that most patients with HFrEF are found to have reduced cardiac index 
(<2.6 L/min/m2).16 and 17 All equations demonstrated >15% of patients with clinically significant 
error at the level of hypoperfusion and >20% of patients with clinically significant error at the 
level of cardiogenic shock. Misclassifying patients at these 2 levels can have significant 
downstream effects in the care and management of patients with moderate-to-severe HFrEF. The 
findings from the present study do not support the use of these empirical formulas to estimate the 
VO2 at rest in patients with HFrEF who underwent right heart catheterization. 
 
This study has limitations. Primarily, patients are generally not accustomed to breathing through 
a mouthpiece; changing the patient's breathing characteristics.18 However, this is a common 
method for measuring VO2 at rest and was the method used by LaFarge and 
Miettinen.4 Furthermore, the proposed sample size was sufficiently powered to compare the 
measured versus the estimated VO2 at rest in the whole sample but was too small to evaluate 
potential confounding factors influencing VO2 at rest (i.e., gender, race, obesity, pulmonary 
hypertension, and so forth) in patients with HFrEF. 
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